Boston, MA -- (SBWire) -- 06/07/2013 --MicroPhage Inc. (MicroPhage) is a medical device development company. The company focuses on patented and proprietary Bacteriophage Amplification Technology (BAT) on the clinical diagnostic market. MicroPhage IVD products enhance the clinician's ability to effectively treat patients, thereby reducing mortality, improving patient condition, reducing hospital length of stay and enhancing antibiotic stewardship. The company's products are bacterial identification and antibiotic susceptibility testing (ID/AST), KeyPath MRSA/MSSA Blood Culture Test - BT and Multiple Pathogen / Multiple Antibiotic Test Panels. The products help physicians to facilitate optimization of antibiotic therapy earlier in the course of disease and save the lives of people. The ID/AST diagnostic test can identify the disease and support antibiotic selection for patients with infections. KeyPath MRSA/MSSA Blood Culture Test - BT identifies Staphylococcus aureus directly from blood cultures for determining methicillin susceptibility (MSSA) or methicillin resistance (MRSA). Multiple Pathogen / Multiple Antibiotic Test Panels product line delivers comprehensive test panels for multiple pathogens and drugs and they are disease- and sample-specific to fit clinical need and laboratory workflow. MicroPhage technology uses bacteriophage amplification marker to identify the presence of viable bacteria and their response to antibiotics, thereby reducing the time and getting to specificity. MicroPhage is headquartered in Longmont, Colorado, the US.
View Full Report Details and Table of Contents
This report is a source for data, analysis and actionable intelligence on the MicroPhage Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Philips Healthcare - Product Pipeline Analysis, 2013 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2013 Update
- Siemens Healthcare - Product Pipeline Analysis, 2013 Update
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2013 Update
- Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2013 Update
- VentriPoint, Inc. - Product Pipeline Analysis, 2013 Update
- C. R. Bard, Inc. (BCR) - Product Pipeline Analysis, 2013 Update
- Alere Inc. (ALR) - Product Pipeline Analysis, 2013 Update
- Covidien plc (COV) - Product Pipeline Analysis, 2013 Update
New Market Study, "MicroPhage Inc. - Product Pipeline Analysis, 2013 Update", Has Been Published
New Medical Devices market report from GlobalData: "MicroPhage Inc. - Product Pipeline Analysis, 2013 Update"